Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following TAVR

Recruiting Observational Study
Conduction Disturbances Transcatheter Aortic Valve Replacement Permanent Pacemaker Implantation
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
2,000 (estimated)
Sponsor
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The high incidence and variety of conduction disturbances post-TAVR represents a major challenge in the periprocedural management of TAVR recipients. Despite the growing body of knowledge on this topic, the large variability in the management of these complications has translated into a high degree of uncertainty regarding the most appropriate treatment of a large proportion of such patients. The …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: -Patients with aortic valve disease undergoing transcatheter aortic valve replacement Exclusion Criteria: * Prior permanent pacemaker * Failure to provide signed informed consent for data collection * Impossibility for a follow-up * Unwillingness to follow the pre-specified st…
Contacts

Josep Rodes-Cabau, MD

418-656-8711

josep.rodes@criucpq.ulaval.ca

CONTACT

Melanie Cote, MSc

418-656-8711

melanie.cote@criucpq.ulaval.ca

CONTACT